SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C198 - Functional Neurologic Disorders I: Movement, Non-epileptic Seizures, and MS-like Disorders

Event Time: Thursday April 27, 2017 1:00 pm to 3:00 pm
Topic(s): General Neurology
Director(s): Alberto Espay MD, FAAN
Description: Through an emphasis on case-based learning, this course will cover the clinician's approach to the diagnosis and initial management of functional movement disorders, functional non-epiletic seizures, and multiple sclerosis-like disorders, including the approach to remove inappropriate medications to minimize iatrogenic harm and “undiagnose” patients with previous diagnosis of epilepsy or multiple sclerosis. This program complements C211: Functional Neurologic Disorders II: Management, CBT, and Inpatient Therapeutic Strategies, but covers independent topics.
Completion Message: Participants should recognize the pearls and pitfalls in the diagnosis of the most common functional neurologic disorders and be in position to apply strategies to minimize iatrogenic harm, correct misdiagnoses, and initiate a treatment plan.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care

Program Speakers - Tentative

Start/End Time Title Faculty
1:00 PM - 1:30 PM An Approach to Functional Movement Disorders Anthony Lang MD, FAAN 
1:30 PM - 2:00 PM An Approach to Functional (Psychogenic Nonepileptic) Seizures W. LaFrance MD, MPH, FAAN 
2:00 PM - 2:30 PM An Approach to Functional Disorders Misdiagnosed as Multiple Sclerosis Andrew Solomon MD 
2:30 PM - 3:00 PM Questions and Answers Faculty 

Disclosures

Speaker Disclosure
W. Curt LaFrance, Jr., MD, MPH, FAAN Dr. LaFrance has nothing to disclose.

Anthony E. Lang, MD, FAAN Dr. Lang has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Abbvie, Acorda, Avanir Pharmaceuticals, Biogen, Bristol Myers Squibb, Sun Pharma, Cipla, Intekrin, Merck, Medichem, Medtronic, Teva, UCB, and Sunovion, . Dr. Lang has received royalty, license fees, or contractual rights payments from Saunders, Wiley-Blackwell, Johns Hopkins Press, and Cambridge University Press.

Andrew Solomon, MD Dr. Solomon has received personal compensation for activities with Teva Pharmaceuticals and EMD Serono as a consultant and/or advisor.

Register Now

Related Courses

Saturday April 21, 2018

7:00 AM-9:00 AM
C2 Functional Neurologic Disorders I: Movement, Seizures, and Speech Disorders Alberto Espay MD, FAAN
7:00 AM-4:00 PM
C6 Neurology MOC Prep Course Nicholas Johnson MD
9:30 AM-11:30 AM
C8 Emergency Neurology: Evaluation of Coma, Meningitis, and Viral Encephalitis in the Emergency Room Jose Suarez MD
C12 Functional Neurologic Disorders II: Life Experiences and Management of Functional Disorders Alberto Espay MD, FAAN
12:00 PM-1:00 PM
Navigating the Annual Meeting App Carlayne Jackson MD, FAAN
1:30 PM-3:30 PM
C22 Critical Care Consultations for Neurohospitalists Vanja Douglas MD
4:15 PM-5:30 PM
PL1 Hot Topics Plenary Session

Wednesday April 25, 2018

7:00 AM-9:00 AM
C139 Neurologic Case Studies in Pregnancy Mary O'Neal MD
9:15 AM-11:30 AM
PL5 Frontiers in Neuroscience Plenary Session
1:00 PM-3:00 PM
C144 Neurology Update I: Epilepsy, Behavioral Neurology, and Neurologic Infections Ralph Jozefowicz MD, FAAN
C148 LGBTQI Health in Neurology Holly Hinson MD, MCR
3:30 PM-5:30 PM
C160 Neurology Update II: Movement Disorders, Spine Disorders, and Sleep Disorders Ralph Jozefowicz MD, FAAN
C168 CNS Toxicities Neeraj Kumar MD

MEMBER LOG IN

Forgot Password?